Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Lancet (London, England)|March 21, 2015
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trialMarco Valgimigli, Andrea Gagnor, Paolo Calabró, et al.
Circulation|October 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary InterventionFelice Gragnano, David van Klaveren, Dik Heg, et al.
Pageof 30